Alvogen Group Overview

  • Year Founded
  • 2007

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 2,800

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 23

  • Investments
  • 18

Alvogen Group General Information

Description

Manufacturer of specialty pharmaceutical, generic, and branded products intended for patients around the world. The company offers a broad range of leading molecules for the treatment of conditions in the areas of oncology, cardiology, respiratory, neurology, and gastroenterology, ensuring affordable generic medications that help reduce healthcare costs around the world.

Contact Information

Website
www.alvogen.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly PE-Backed
Corporate Office
  • 44 Whippany Road
  • Suite 300
  • Morristown, NJ 07960
  • United States
+1 (973)
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Parent Company
Corporate Office
  • 44 Whippany Road
  • Suite 300
  • Morristown, NJ 07960
  • United States
+1 (973)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Alvogen Group Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Alvogen Group‘s full profile, request access.

Request a free trial

Alvogen Group Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Manufacturer of specialty pharmaceutical, generic, and branded products intended for patients around the world. The comp
Drug Discovery
Morristown, NJ
2,800 As of 2017

Monmouth Junction, NJ
 

Dublin, Ireland
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Alvogen Group Competitors (40)

One of Alvogen Group’s 40 competitors is Tris Pharma, a Private Debt Financed company based in Monmouth Junction, NJ.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Tris Pharma Private Debt Financed Monmouth Junction, NJ
Alkermes Formerly VC-backed Dublin, Ireland
Bluefish Pharmaceuticals Private Equity-Backed Stockholm, Sweden
CMP Pharma Formerly PE-Backed Farmville, NC
MS Pharma Private Equity-Backed Amman, Jordan
You’re viewing 5 of 40 competitors. Get the full list »

Alvogen Group Patents

Alvogen Group Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3760190-A1 Controlled-release tablets of pregabalin, method of making, and method of use thereof Active 03-Jul-2019
EP-3760190-B1 Controlled-release tablets of pregabalin, method of making, and method of use thereof Active 03-Jul-2019
US-11974974-B2 Controlled-release tablets, method of making, and method of use thereof Active 03-Jul-2019
US-20210000775-A1 Controlled-release tablets, method of making, and method of use thereof Active 03-Jul-2019
ES-2953059-T3 Pregabalin controlled release tablets, method of manufacture, and method of use thereof Active 03-Jul-2019 A61K9/2027
To view Alvogen Group’s complete patent history, request access »

Alvogen Group Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Alvogen Group Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Alvogen Group‘s full profile, request access.

Request a free trial

Alvogen Group Investments & Acquisitions (18)

Alvogen Group’s most recent deal was a PE Growth/Expansion with Alvotech for . The deal was made on 23-Oct-2020.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Alvotech 23-Oct-2020 PE Growth/Expansion Pharmaceuticals
Assertio Therapeutics (Gralise) 13-Jan-2020 Buyout/LBO Buildings and Property
Almaject 01-Jan-2018 Buyout/LBO Medical Supplies
Bittner Pharma 21-Jul-2017 Merger/Acquisition Pharmaceuticals
County Line Pharmaceuticals 13-Apr-2016 Buyout/LBO Pharmaceuticals
You’re viewing 5 of 18 investments and acquisitions. Get the full list »

Alvogen Group Exits (2)

Alvogen Group’s most recent exit was on 23-Oct-2020 from Alvotech. The exit was categorized as with 5 buyers.

Company Name Exit Date Exit Type Exit Size Status Buyers
Alvotech 23-Oct-2020 Completed
  • 5 buyers
Labormed Alvogen 01-Dec-2012 Merger/Acquisition Completed
To view Alvogen Group’s complete exits history, request access »

Alvogen Group Affiliates

Subsidiaries (3)

Name Industry Location Year Founded
Almatica Pharma Morristown, NJ 2007
Alvogen Korea Seoul, South Korea 1958
Almaject Morristown, NJ

Alvogen Group FAQs

  • When was Alvogen Group founded?

    Alvogen Group was founded in 2007.

  • Where is Alvogen Group headquartered?

    Alvogen Group is headquartered in Morristown, NJ.

  • What is the size of Alvogen Group?

    Alvogen Group has 2,800 total employees.

  • What industry is Alvogen Group in?

    Alvogen Group’s primary industry is Drug Discovery.

  • Is Alvogen Group a private or public company?

    Alvogen Group is a Private company.

  • What is the current valuation of Alvogen Group?

    The current valuation of Alvogen Group is .

  • What is Alvogen Group’s current revenue?

    The current revenue for Alvogen Group is .

  • How much funding has Alvogen Group raised over time?

    Alvogen Group has raised $2.56B.

  • Who are Alvogen Group’s investors?

    AFI Partners, Alvogen Lux Holdings, Athyrium Capital Management, Aztiq Pharma Partners, and Benefit Street Partners are 5 of 12 investors who have invested in Alvogen Group.

  • Who are Alvogen Group’s competitors?

    Tris Pharma, Alkermes, Bluefish Pharmaceuticals, CMP Pharma, and MS Pharma are some of the 40 competitors of Alvogen Group.

  • When was Alvogen Group acquired?

    Alvogen Group was acquired on 03-Dec-2025.

  • Who acquired Alvogen Group?

    Alvogen Group was acquired by Lotus Pharmaceutical.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process